{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:41Z","timestamp":1767134921759,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":69,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007811","type":"reference-entry","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T15:23:45Z","timestamp":1239809025000},"source":"Crossref","is-referenced-by-count":14,"title":["Sulpiride versus placebo for schizophrenia"],"prefix":"10.1002","author":[{"given":"Ichiro M","family":"Omori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"10.1002\/14651858.CD007811-BIB1|cit1","first-page":"453","article-title":"Clinical trial with sulpiride and placebo in chronic schizophrenics study of 89 patients using the Harris-Letemendia-Willems scale","volume":"35","author":"Mezquita Blanco","year":"1972","journal-title":"Archivos de Neurobiologia - Madrid"},{"key":"10.1002\/14651858.CD007811-BIB2|cit2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hup.470050308","article-title":"Sulpiride in negative schizophrenia - a placebo-controlled double-blind assessment","volume":"5","author":"Soni","year":"1990","journal-title":"Human Psychopharmacology Clinical and Experimental"},{"issue":"15","key":"10.1002\/14651858.CD007811-BIB3|cit3","first-page":"958","article-title":"Contribution to the clinical study of a new neuroleptic: sulpiride","volume":"45","author":"Benoit","year":"1969","journal-title":"Semaine des Hopitaux"},{"issue":"6","key":"10.1002\/14651858.CD007811-BIB4|cit4","first-page":"20","article-title":"A comparison study of using clozapine in combination with sulpiride and simple using clozapine or sulpiride in treatment schizophrenia","volume":"2","author":"Gong","year":"2001","journal-title":"Journal of Chinease Clinical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007811-BIB5|cit5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-200401000-00004","article-title":"Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatology","volume":"19","author":"Kotler","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007811-BIB6|cit6","first-page":"87","article-title":"A control study of clozapine in combination with sulpiride in alleviating the negative symptoms of schizophrenia","volume":"29","author":"Liu","year":"1996","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007811-BIB7|cit7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1192\/bjp.171.6.569","article-title":"Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study","volume":"171","author":"Shiloh","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007811-BIB8|cit8","first-page":"148","article-title":"A clinical effect and following-up study about sulpiride and clozapine for 105 cases of the schizophrenia type ?","volume":"11","author":"Wang","year":"1994","journal-title":"Journal of Xinxiang Medical College"},{"issue":"7","key":"10.1002\/14651858.CD007811-BIB9|cit9","first-page":"639","article-title":"Clinical controlled studies of olanzapine combined with sulpiride therapy in refractory schizophrenia","volume":"14","author":"Wu","year":"2005","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"4","key":"10.1002\/14651858.CD007811-BIB10|cit10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00213-006-0384-5","article-title":"Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia","volume":"186","author":"Wu","year":"2006","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD007811-BIB11|cit11","first-page":"24","article-title":"Observation on intractable auditory hallucination treated by injecting sulpiride into acupoints","volume":"16","author":"Yang","year":"2000","journal-title":"Journal of Practical Traditional Chinese Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007811-BIB12|cit12","first-page":"250","article-title":"A double blind randomized study comparing clozapine and clozapine combination with sulpiride in the treatment of schizophrenia","volume":"12","author":"Yao","year":"1999","journal-title":"Sichuan Mental Health"},{"issue":"3","key":"10.1002\/14651858.CD007811-BIB13|cit13","first-page":"224","article-title":"Comparison of sulpiride and chlorpromazine in treatment of negative psychotic symptoms with chronic schizophrenia","volume":"11","author":"Zhao","year":"2003","journal-title":"Health Psychology Journal"},{"issue":"4","key":"10.1002\/14651858.CD007811-BIB14|cit14","first-page":"204","article-title":"A controlled trial comparing clomipramine and sulpiride as adjunct to clozapine in the treatment of negative symptoms of schizophrenia","volume":"9","author":"Zhu","year":"1999","journal-title":"Journal of Clinical Psychological Medicine"},{"key":"10.1002\/14651858.CD007811-BIB15|cit15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00431993","article-title":"Sulpiride in tardive dyskinesia","volume":"66","author":"Casey","year":"1979","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007811-BIB16|cit16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/bmj.313.7066.1200","article-title":"The clinical efficacy of sulpiride in the treatment of type II schizophrenia","volume":"28","author":"Hong","year":"1995","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD007811-BIB17|cit17","unstructured":"Ma P Tianma (gastrodia elata B1) for schizophrenia Stanley Foundation Research Programs 2009"},{"issue":"8","key":"10.1002\/14651858.CD007811-BIB18|cit18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.47.8.844","article-title":"A DOUBLE BLIND trial of sulpiride in Huntington's disease and tardive dyskinesia","volume":"47","author":"Quinn","year":"1984","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"19","key":"10.1002\/14651858.CD007811-BIB19|cit19","first-page":"1376","article-title":"DOUBLE BLIND trial of dogmatil in Huntington chorea and tardive dyskinesia","volume":"61","author":"Quinn","year":"1985","journal-title":"Semaine des Hopitaux"},{"key":"10.1002\/14651858.CD007811-BIB20|cit20","unstructured":"Sahakian BJ Sulpiride effects on cognitive function in healthy volunteers National Research Register 2000"},{"issue":"9","key":"10.1002\/14651858.CD007811-BIB21|cit21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/bmj.315.7108.600","article-title":"Sulpiride in tardive dyskinesia","volume":"53","author":"Schwartz","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007811-BIB22|cit22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-8760(94)90046-9","article-title":"Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value","volume":"16","author":"Takeshita","year":"1994","journal-title":"International Journal of Psychophysiology"},{"key":"10.1002\/14651858.CD007811-BIB23|cit23","unstructured":"Wuliji O Eight week double-blind, placebo-controlled, randomized, trial of the traditional Mongolian medical prescription shuangzao mixture added to sulpiride in 200 patients with schizophrenia Stanley Foundation Research Programs 2003"},{"key":"10.1002\/14651858.CD007811-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007811-BIB25|cit25","volume-title":"Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1984"},{"key":"10.1002\/14651858.CD007811-BIB26|cit26","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD007811-BIB27|cit27","first-page":"453","article-title":"The atypical neuroleptic concept","volume":"18","author":"Azorin","year":"1992","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD007811-BIB28|cit28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"7108","key":"10.1002\/14651858.CD007811-BIB29|cit29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ (Clinical research ed.)"},{"issue":"4","key":"10.1002\/14651858.CD007811-BIB30|cit30","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD007811-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.315.7109.629","article-title":"Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study","volume":"60","author":"Bratfos","year":"1979","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD007811-BIB32|cit32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/106002809502900210","article-title":"Sulpiride: an antipsychotic with selective dopaminergic antagonist properties","volume":"2","author":"Caley","year":"1995","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD007811-BIB33|cit33","first-page":"560","article-title":"Study of the effects of sulpiride on the mental state of 40 mental patients","volume":"2","author":"Carrere","year":"1968","journal-title":"Annales Medico Psychologiques Paris"},{"issue":"7","key":"10.1002\/14651858.CD007811-BIB34|cit34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2471\/BLT.07.045377","article-title":"Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis","volume":"86","author":"Chisholm","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD007811-BIB35|cit35","series-title":"Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Issues in the selection for meta-analyses of binary data","author":"Deeks"},{"issue":"6","key":"10.1002\/14651858.CD007811-BIB36|cit36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD007811-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in medicine"},{"key":"10.1002\/14651858.CD007811-BIB38|cit38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.137.6.522","article-title":"Controlled trial of sulpiride in chronic schizophrenic patients","volume":"137","author":"Edwards","year":"1980","journal-title":"British Journal of Psychiatry"},{"issue":"7109","key":"10.1002\/14651858.CD007811-BIB39|cit39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical research ed.)"},{"issue":"1","key":"10.1002\/14651858.CD007811-BIB40|cit40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International journal of epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007811-BIB41|cit41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archpsyc.60.5.458","article-title":"Placebo or active control trials of antipsychotic drugs?","volume":"60","author":"Fleischhacker","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007811-BIB42|cit42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/schbul\/17.2.289","article-title":"New antipsychotics: classification, efficacy, and adverse effects","volume":"17","author":"Gerlach","year":"1991","journal-title":"Schizophrenia Bulletin"},{"issue":"9","key":"10.1002\/14651858.CD007811-BIB43|cit43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American journal of epidemiology"},{"key":"10.1002\/14651858.CD007811-BIB44|cit44","volume-title":"Clinincal Global Impression (CGI). In: Early clinical drug evaluation (ECDUE) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"11","key":"10.1002\/14651858.CD007811-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in medicine"},{"key":"10.1002\/14651858.CD007811-BIB46|cit46","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD007811-BIB47|cit47","article-title":"Mental disorders","volume-title":"Disease Control Priorities in Developing Countries","author":"Hyman","year":"2006"},{"key":"10.1002\/14651858.CD007811-BIB48|cit48","volume-title":"Positive and Negative Syndrome Scale(PANSS) manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD007811-BIB49|cit49","doi-asserted-by":"crossref","unstructured":"Kerwin RW The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research The British journal of psychiatry : the journal of mental science 1994 141 8","DOI":"10.1192\/bjp.164.2.141"},{"issue":"4","key":"10.1002\/14651858.CD007811-BIB50|cit50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardized psychiatric assessment scale for rating chronic psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD007811-BIB51|cit51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"The British journal of psychiatry : the journal of mental science"},{"issue":"2-3","key":"10.1002\/14651858.CD007811-BIB52|cit52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia research"},{"key":"10.1002\/14651858.CD007811-BIB53|cit53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"The British journal of psychiatry : the journal of mental science"},{"issue":"5","key":"10.1002\/14651858.CD007811-BIB54|cit54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1192\/bjp.169.5.580","article-title":"The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization","volume":"169","author":"Mason","year":"1996","journal-title":"The British journal of psychiatry : the journal of mental science"},{"issue":"2","key":"10.1002\/14651858.CD007811-BIB55|cit55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0278-5846(94)90067-1","article-title":"L-sulpiride in young and elderly negative schizophrenics: clinical and pharmacokinetic variables","volume":"8","author":"Mauri","year":"1994","journal-title":"Progress in Neuro Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007811-BIB56|cit56","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2165\/00002018-199614050-00003","article-title":"A risk-benefit assessment of sulpiride in the treatment of schizophrenia","volume":"14","author":"Mauri","year":"1996","journal-title":"Drug Safety"},{"issue":"7400","key":"10.1002\/14651858.CD007811-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.326.7400.1171","article-title":"Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications","volume":"326","author":"Melander","year":"2003","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD007811-BIB58|cit58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/9780470987353.ch24","article-title":"Acute pharmacological treatment of schizophrenia","volume-title":"Schizophrenia","author":"Myamoto","year":"2003"},{"key":"10.1002\/14651858.CD007811-BIB59|cit59","first-page":"164","article-title":"Clinico-pharmacological studies of sulpiride","volume":"20","author":"Nishiura","year":"1976","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD007811-BIB60|cit60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD007811-BIB61|cit61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1192\/bjp.136.4.384","article-title":"The disabilities of chronic schizophrenia: their nature and the factors contributing to their development","volume":"136","author":"Owens","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007811-BIB62|cit62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/bmb\/ldm010","article-title":"Mental health in low- and middle-income countries","volume":"81-82","author":"Patel","year":"2007","journal-title":"British medical bulletin"},{"key":"10.1002\/14651858.CD007811-BIB63|cit63","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1192\/bjp.150.2.270a","article-title":"The effect of sulpiride on negative symptoms of schizophrenia","volume":"150","author":"Petit","year":"1987","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007811-BIB64|cit64","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","article-title":"Size of burden of schizophrenia and psychotic disorders","volume":"15","author":"Rossler","year":"2005","journal-title":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007811-BIB65|cit65","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"issue":"5","key":"10.1002\/14651858.CD007811-BIB66|cit66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA : the journal of the American Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD007811-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD007811-BIB68|cit68","series-title":"15th Cochrane Colloquium, Sao Paulo, 23-27 October 2007","article-title":"[P85] The Leeds Outcomes Stakeholders Survey (LOSS) Study","author":"Xia","year":"2007"},{"issue":"1","key":"10.1002\/14651858.CD007811-BIB69|cit69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001162","article-title":"Sulpiride for schizophrenia","author":"Soares","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007811.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007811\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:14:03Z","timestamp":1628532843000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007811"}},"subtitle":[],"editor":[{"given":"Ichiro M","family":"Omori","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007811","relation":{},"subject":[],"published":{"date-parts":[[2009,4,15]]}}}